Pneumonia News and Research

Latest Pneumonia News and Research

Diffregen awarded SBIR Phase 1 grant to advance Angiocidin towards human clinical trials

Diffregen LLC, a Temple University startup company, has been awarded a small business innovation research Phase 1 grant by the National Cancer Institute to advance Angiocidin, a university-created therapeutic to treat acute myeloid leukemia, to the doorstep of human clinical trials.

24 Oct 2013

New flu vaccine offers better protection against circulating flu viruses

Last year's flu season was considered one of the strongest and deadliest in recent decades, according to the CDC. In preparation for this year's flu season, Concentra, a subsidiary of Humana Inc., offers a flu vaccine to provide greater protection against circulating flu strains.

23 Oct 2013

EvergreenHealth named one of America's 100 Best Hospitals in three specialty areas

EvergreenHealth today announced it has earned several distinctions for 2014 across many of the health care system's specialties from Healthgrades, the nation's leading independent provider of information to help consumers make informed decisions about a physician or hospital.

23 Oct 2013

Cedars-Sinai wins national consumer award for providing quality medical care, staff in LA region

For the 18th year in a row, Cedars-Sinai has won a national consumer award for providing the highest quality medical care and staff in the Los Angeles region based on a survey of area households.

22 Oct 2013

‘Limit diagnostic investigations’ in children with recurrent CAP

Research shows that pediatric recurrent community-acquired pneumonia in different lung areas is most commonly associated with mild conditions like rhinosinusitis and asthma, and not severe underlying disease.

21 Oct 2013

Research roundup: Less savings needed for retirement health expenses; falls as a predictor of surgical outcomes

Each week, KHN compiles a selection of recently released health policy studies and briefs.

19 Oct 2013

Oral nutritional supplements linked with decreased probability of 30-day hospital readmission

In the U.S., one in five Medicare patients is readmitted to a hospital each year at an estimated cost of $17.5 billion annually.i To reduce this impact, the Affordable Care Act (ACA) has introduced hospital penalties based on readmissions conditions that commonly affect patients aged 65 and older - including acute myocardial infarction, congestive heart failure and pneumonia.

19 Oct 2013

European Commission approves updated label of Prevenar 13 for high risk pneumococcal disease

Pfizer Inc. (NYSE:PFE) announced today that the European Commission approved updates to the Summary of Product Characteristics (SmPC) for the company's pneumococcal conjugate vaccine Prevenar 13* (pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]), regarding its use in certain populations at high risk of pneumococcal disease.

18 Oct 2013

$Vertebral augmentation for spinal fractures improves patient survival, reduces overall costs$

Vertebral augmentation for spinal fractures improves patient survival, reduces overall costs

A study of 69,000 Medicare patient records led by Johns Hopkins researchers shows that people with spine compression fractures who undergo operations to strengthen back bones with cement survive longer and have shorter overall hospital stays than those who stick with bed rest, pain control and physical therapy.

18 Oct 2013

Researchers identify novel gene mutation that causes common variable immunodeficiency

A 30-year-old woman with a history of upper respiratory infections had no idea she carried an immunodeficiency disorder - until her 6-year-old son was diagnosed with the same illness.

18 Oct 2013

Study focuses on vaccine-preventable illnesses in myasthenia gravis patients

A study presented at the annual meeting of the American Association of Neuromuscular & Electrodiagnostic Medicine is considered a good first step in collecting data on vaccine-preventable illnesses in patients with myasthenia gravis, a neuromuscular disorder causing weakness and rapid fatigue of voluntary muscles.

17 Oct 2013

New England publishes results of phase III clinical trial of ABRAXANE for metastatic pancreatic cancer

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation , today announced the results of the MPACT phase III clinical trial of ABRAXANE® in combination with gemcitabine were published online in the October 16th edition of the New England Journal of Medicine.

17 Oct 2013

Ticagrelor drug may reduce risk of dying following heart attack

Scientists from the University of Sheffield have discovered ground breaking clues as to how the pioneering heart drug ticagrelor might reduce the risk of dying following a heart attack, in comparison to previous standard treatments.

16 Oct 2013

New type of antibiotic kills multidrug-resistant germ common to health care settings

A new type of antibiotic called a PPMO, which works by blocking genes essential for bacterial reproduction, successfully killed a multidrug-resistant germ common to health care settings, UT Southwestern Medical Center researchers report.

16 Oct 2013

Research finding may help patients to better survive severe infectious diseases

Scientists of Charité - Universitätsmedizin Berlin for the first time have solved the 3-dimensional structure of the protein LBP and it´s genetic variant. This finding may help certain patients to better survive severe infectious diseases. The results have been published in the recent issue of the journal Immunity.

15 Oct 2013

Study: Statin do not improve VAP outcomes

Laurent Papazian, M.D., Ph.D., of H-pital Nord, Marseille, France, and colleagues conducted a study to determine whether statin therapy decreased day-28 mortality among intensive care unit patients with ventilator-associated pneumonia.

11 Oct 2013

Lakewood-Amedex, Wainwright enter into strategic advisory agreement

Lakewood-Amedex Inc., a leading developer of novel anti-infective pharmaceuticals, announced today that it has entered into a strategic advisory agreement with H.C. Wainwright & Co., LLC.

9 Oct 2013

Study explores impact of altitude and anemia in children with pneumonia

Pneumonia is the leading cause of death of young children around the world, and a study from an international group of researchers now finds that the risk of poor outcomes - including persistent pneumonia, secondary infections, organ failure or death - in children who contract pneumonia is four times higher in those who also have anemia and live at high altitudes (over 2,000 meters or about 6,500 feet).

9 Oct 2013

FMCNA encourages dialysis patients to get vaccinated against flu

With early cases of seasonal flu already being reported in the U.S., Fresenius Medical Care North America (FMCNA), the nation's leading network of dialysis facilities, is strongly encouraging dialysis patients to get flu shots to protect themselves against this common infectious disease.

9 Oct 2013

Hyperglycemia heightens pneumonia risk in pediatric burns patients

Research indicates that hyperglycemia puts pediatric burns patients at increased risk for pneumonia.

8 Oct 2013

Pneumonia News and Research

Latest Pneumonia News and Research

Diffregen awarded SBIR Phase 1 grant to advance Angiocidin towards human clinical trials

New flu vaccine offers better protection against circulating flu viruses

EvergreenHealth named one of America's 100 Best Hospitals in three specialty areas

Cedars-Sinai wins national consumer award for providing quality medical care, staff in LA region

‘Limit diagnostic investigations’ in children with recurrent CAP

Research roundup: Less savings needed for retirement health expenses; falls as a predictor of surgical outcomes

Oral nutritional supplements linked with decreased probability of 30-day hospital readmission

European Commission approves updated label of Prevenar 13 for high risk pneumococcal disease

Vertebral augmentation for spinal fractures improves patient survival, reduces overall costs

Researchers identify novel gene mutation that causes common variable immunodeficiency

Study focuses on vaccine-preventable illnesses in myasthenia gravis patients

New England publishes results of phase III clinical trial of ABRAXANE for metastatic pancreatic cancer

Ticagrelor drug may reduce risk of dying following heart attack

New type of antibiotic kills multidrug-resistant germ common to health care settings

Research finding may help patients to better survive severe infectious diseases

Study: Statin do not improve VAP outcomes

Lakewood-Amedex, Wainwright enter into strategic advisory agreement

Study explores impact of altitude and anemia in children with pneumonia

FMCNA encourages dialysis patients to get vaccinated against flu

Hyperglycemia heightens pneumonia risk in pediatric burns patients

Innovation in neuroscience drug discovery - eBook eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Pneumonia News and Research

Latest Pneumonia News and Research

Innovation in neuroscience drug discovery - eBook eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in